Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Theravance Biopharma Q1 EPS $(0.27) Misses $(0.23) Estimate, Sales $15.39M Miss $15.50M Estimate

Author: Benzinga Newsdesk | May 08, 2025 03:09pm
Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.23) by 17.39 percent. This is a 200 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $15.39 million which missed the analyst consensus estimate of $15.50 million by 0.72 percent. This is a 6.10 percent increase over sales of $14.50 million the same period last year.

Posted In: TBPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist